SLS ranked third in Tendie.bot's ticker ranking on January 6, 2026, with 8 posts, 74 comments, and a sentiment score of 0.625.
A bear-case due-diligence post on r/pennystocks raised questions about the CEO's medical credentials, sparking 116 comments and intense debate.
Retail investors also discussed SLS as a short-term growth play alongside RZLV and MVIS, with one user starting a $500 biweekly experiment buying SLS at $4.58.
SELLAS Life Sciences Group (![]()
Bullish Bets and a Trading Experiment
On r/pennystocks, a user seeking advice on short-term growth listed ![]()
![]()
Bearish Due Diligence Sparks Heated Debate
The most engaged discussion came from a bear-case analysis of ![]()
Market Context and Sentiment
No same-day news articles were ingested for ![]()
As the debate continues, ![]()
Subscribe to Tendie.bot for more market recaps.
